Nancy Roach

2.9k total citations
35 papers, 1.7k citations indexed

About

Nancy Roach is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Economics and Econometrics. According to data from OpenAlex, Nancy Roach has authored 35 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 13 papers in Oncology and 11 papers in Economics and Econometrics. Recurrent topics in Nancy Roach's work include Colorectal Cancer Treatments and Studies (11 papers), Ethics in Clinical Research (11 papers) and Cancer Treatment and Pharmacology (8 papers). Nancy Roach is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Ethics in Clinical Research (11 papers) and Cancer Treatment and Pharmacology (8 papers). Nancy Roach collaborates with scholars based in United States, United Kingdom and Netherlands. Nancy Roach's co-authors include Stanley R. Hamilton, Pamela B. Mangu, Carolyn D. Runowicz, Francisco García, Kenneth D. Hatch, Kenneth L. Noller, Thomas C. Wright, Debbie Saslow, Diane Solomon and J. Thomas Cox and has published in prestigious journals such as Journal of Clinical Oncology, Nature Reviews Drug Discovery and European Journal of Cancer.

In The Last Decade

Nancy Roach

34 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Roach United States 19 788 423 366 302 288 35 1.7k
Katherine Van Loon United States 21 956 1.2× 256 0.6× 213 0.6× 293 1.0× 270 0.9× 126 1.7k
Alice Nennecke Germany 14 1.2k 1.5× 310 0.7× 233 0.6× 203 0.7× 358 1.2× 36 2.0k
Patricia M. Jamison United States 13 1.4k 1.7× 393 0.9× 323 0.9× 397 1.3× 307 1.1× 19 2.5k
Henrike E. Karim‐Kos Netherlands 27 1.4k 1.7× 396 0.9× 379 1.0× 261 0.9× 453 1.6× 67 2.7k
Daniela Cristina Stefan South Africa 25 704 0.9× 279 0.7× 267 0.7× 209 0.7× 164 0.6× 91 1.8k
Magdalena Bielska‐Lasota Poland 10 1.0k 1.3× 274 0.6× 141 0.4× 193 0.6× 330 1.1× 26 1.8k
Eva Segelov Australia 25 1.4k 1.8× 526 1.2× 253 0.7× 218 0.7× 417 1.4× 158 2.4k
Sheetal Kircher United States 22 972 1.2× 222 0.5× 218 0.6× 147 0.5× 199 0.7× 108 1.8k
Lewis E. Foxhall United States 15 623 0.8× 415 1.0× 177 0.5× 158 0.5× 165 0.6× 29 1.5k
Shibao Feng United States 20 948 1.2× 336 0.8× 347 0.9× 134 0.4× 192 0.7× 52 1.9k

Countries citing papers authored by Nancy Roach

Since Specialization
Citations

This map shows the geographic impact of Nancy Roach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Roach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Roach more than expected).

Fields of papers citing papers by Nancy Roach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Roach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Roach. The network helps show where Nancy Roach may publish in the future.

Co-authorship network of co-authors of Nancy Roach

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Roach. A scholar is included among the top collaborators of Nancy Roach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Roach. Nancy Roach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Treiman, Katherine, Lauren McCormack, Laura Wagner, et al.. (2018). Factors affecting the communication experiences of newly diagnosed colorectal cancer patients. Patient Education and Counseling. 101(9). 1585–1593. 13 indexed citations
2.
Reeve, Bryce B., David Thissen, Carla Bann, et al.. (2017). Psychometric evaluation and design of patient-centered communication measures for cancer care settings. Patient Education and Counseling. 100(7). 1322–1328. 46 indexed citations
3.
Perez, Raymond P., Patrick Archdeacon, Nancy Roach, et al.. (2017). Sponsors’ and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trials. Clinical Trials. 14(3). 225–233. 6 indexed citations
4.
Treiman, Katherine, Lauren McCormack, Murrey Olmsted, et al.. (2016). Engaging Patient Advocates and Other Stakeholders to Design Measures of Patient-Centered Communication in Cancer Care. Patient. 10(1). 93–103. 21 indexed citations
5.
Roach, Nancy, et al.. (2016). Enhancing clinical evidence by proactively building quality into clinical trials. Clinical Trials. 13(4). 439–444. 47 indexed citations
6.
Wong, Yu-Ning, Nancy Roach, & Neal J. Meropol. (2016). Addressing Patients’ Priorities as a Strategy to Improve Value. The Oncologist. 21(11). 1279–1282. 5 indexed citations
7.
Ellis, Lee M., Charles D. Blanke, & Nancy Roach. (2015). Losing “Losing the Battle With Cancer”. JAMA Oncology. 1(1). 13–13. 15 indexed citations
8.
Perlmutter, Jane, Nancy Roach, & Mary Lou Smith. (2015). Involving Advocates in Cancer Research. Seminars in Oncology. 42(5). 681–685. 12 indexed citations
9.
10.
Eng, Cathy, et al.. (2015). Perspectives on Clinical Trials for Gastrointestinal Malignancies. American Society of Clinical Oncology Educational Book. 40–43. 1 indexed citations
11.
Wong, Yu-Ning, Mark Schluchter, Terrance L. Albrecht, et al.. (2015). Financial Concerns About Participation in Clinical Trials Among Patients With Cancer. Journal of Clinical Oncology. 34(5). 479–487. 31 indexed citations
12.
Fleisher, Linda, Dominique G. Ruggieri, Sharon L. Manne, et al.. (2014). Application of best practice approaches for designing decision support tools: The preparatory education about clinical trials (PRE-ACT) study. Patient Education and Counseling. 96(1). 63–71. 27 indexed citations
13.
Hurwitz, Herbert I., Tanios Bekaii‐Saab, Johanna C. Bendell, et al.. (2014). Safety and Effectiveness of Bevacizumab Treatment for Metastatic Colorectal Cancer: Final Results from the Avastin® Registry – Investigation of Effectiveness and Safety (ARIES) Observational Cohort Study. Clinical Oncology. 26(6). 323–332. 24 indexed citations
14.
Manne, Sharon L., Deborah A. Kashy, Terrance L. Albrecht, et al.. (2014). Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers. European Journal of Cancer Care. 24(1). 28–38. 32 indexed citations
15.
Fridlyand, Jane, Richard Simon, Jessica C. Walrath, et al.. (2013). Considerations for the successful co-development of targeted cancer therapies and companion diagnostics. Nature Reviews Drug Discovery. 12(10). 743–755. 54 indexed citations
16.
Manne, Sharon L., Deborah A. Kashy, Terrance L. Albrecht, et al.. (2013). Knowledge, Attitudes, and Self-efficacy as Predictors of Preparedness for Oncology Clinical Trials. Medical Decision Making. 34(4). 454–463. 16 indexed citations
17.
18.
Eads, Jennifer R., Terrance L. Albrecht, Brian L. Egleston, et al.. (2011). Identification of barriers to clinical trials: The impact of education level.. Journal of Clinical Oncology. 29(15_suppl). 6003–6003. 7 indexed citations
19.
Amit, Ohad, et al.. (2010). Blinded Independent Central Review of the Progression-Free Survival Endpoint. The Oncologist. 15(5). 492–495. 29 indexed citations
20.
Wright, Thomas C., Mark Schiffman, Diane Solomon, et al.. (2004). Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening. Obstetrics and Gynecology. 103(2). 304–309. 391 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine Van Loon Breakdown of academic impact, for papers by Alice Nennecke Breakdown of academic impact, for papers by Patricia M. Jamison Breakdown of academic impact, for papers by Henrike E. Karim‐Kos Breakdown of academic impact, for papers by Daniela Cristina Stefan Breakdown of academic impact, for papers by Magdalena Bielska‐Lasota Breakdown of academic impact, for papers by Eva Segelov Breakdown of academic impact, for papers by Sheetal Kircher Breakdown of academic impact, for papers by Lewis E. Foxhall Breakdown of academic impact, for papers by Shibao Feng
Rankless by CCL
2026